跳至主要内容
临床试验/CTRI/2021/09/036647
CTRI/2021/09/036647已完成3 期

Comparison of Topical Purslane & topical 0.1% triamcinolone acetonide in the management of Oral Lichen Planus - A double blinded clinical trial

Dr Arul Jothi Murugan0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are willing to participate in the study.
  • Patients with symptomatic (burning sensation or pain) reticular type oral lichen planus and who had not under gone any previous treatment for the same in the last six months.
  • Clinically and histopathologically confirmed Oral lichen Planus.
  • Patients with other systemic diseases ( Diaebtes & hypertension) & those not under any long term glucocorticosteroid therapy.

排除标准

  • Histopathologically proven lichenoid reaction.
  • Patients with other white lesions like leukoplakia, systemic lupus erythematosus(SLE) along with oral lichen planus.
  • Patients with other systemic diseases & those on long term glucocorticosteroid therapy.
  • Patients having extra oral manifestations of oral lichen planus during the duration of treatment.
  • Pregnancy, lactation.
  • History of allergic reactions to herbal preparations.

研究者

发起方
Dr Arul Jothi Murugan

相似试验